Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L van Heerebeek

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|February 25, 2016
Understanding heart failure with preserved ejection fraction: where are we today?L van Heerebeek, W J Paulus
Journal of Clinical Pathology|July 31, 2002
NADPH oxidase(s): new source(s) of reactive oxygen species in the vascular system?L Van Heerebeek, C Meischl, W Stooker, et al.
ESMO Open|February 16, 2024
Clinical presentation of cardiac symptoms following treatment with tumor-infiltrating lymphocytes: diagnostic challenges and lessons learnedJ S W Borgers, A W van Schijndel, J V van Thienen, et al.
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|November 29, 2019
A randomised comparison of the effect of haemodynamic monitoring with CardioMEMS in addition to standard care on quality of life and hospitalisations in patients with chronic heart failure : Design and rationale of the MONITOR HF multicentre randomised clinical trialJ J Brugts, J F Veenis, S P Radhoe, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|February 25, 2016
Understanding heart failure with preserved ejection fraction: where are we today?L van Heerebeek, W J Paulus
Journal of Clinical Pathology|July 31, 2002
NADPH oxidase(s): new source(s) of reactive oxygen species in the vascular system?L Van Heerebeek, C Meischl, W Stooker, et al.
ESMO Open|February 16, 2024
Clinical presentation of cardiac symptoms following treatment with tumor-infiltrating lymphocytes: diagnostic challenges and lessons learnedJ S W Borgers, A W van Schijndel, J V van Thienen, et al.
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|November 29, 2019
A randomised comparison of the effect of haemodynamic monitoring with CardioMEMS in addition to standard care on quality of life and hospitalisations in patients with chronic heart failure : Design and rationale of the MONITOR HF multicentre randomised clinical trialJ J Brugts, J F Veenis, S P Radhoe, et al.
Pageof 1